Literature DB >> 12135040

Effect of the interaction between steatosis and alcohol intake on liver fibrosis progression in chronic hepatitis C.

Lawrence Serfaty1, Armelle Poujol-Robert, Nicolas Carbonell, Olivier Chazouillères, Renée E Poupon, Raoul Poupon.   

Abstract

OBJECTIVES: Liver steatosis is a common histopathological finding in patients infected with hepatitis C virus. Patients with chronic hepatitis C having both steatosis and factors causing oxidative stress may be at a higher risk of fibrogenesis. In a subset of patients with a definite date of contamination, our study aimed to assess the potential synergistic interaction between steatosis and factors likely to induce oxidative stress-namely, alcohol intake, iron overload, and drugs.
METHODS: Out of 700 anti-HCV-positive screened patients, 142 untreated patients with liver biopsy and with one known risk factor were selected. Liver fibrosis, inflammation, and necrosis were graded according to the Knodell score, and steatosis as moderate to severe if more than 30% of hepatocytes were affected. Drinkers were defined as having daily mean alcohol intakes of more than 30 g in men and 20 g in women.
RESULTS: In multivariate analysis, two factors were independently associated with extensive fibrosis: the degree of severity of piecemeal necrosis (OR = 3.27, CI = 1 .17-9.16) and a combination of moderate to severe steatosis and alcohol intake (OR = 7.02, CI = 1.12-44). The median progression rate of fibrosis was about twice as high among drinkers with steatosis than among drinkers without steatosis or nondrinkers with or without steatosis (0.25 vs 0. I vs 0.13 vs 0.08, respectively; p = 0.02). Independent parameters significantly associated with moderate to severe steatosis were body mass index (OR = 1.13, CI = 1.02-1.26) and infection with genotype 3 (OR = 5.5, CI = 1.88-16), but not alcohol consumption.
CONCLUSIONS: As well as the key role of the severity of piecemeal necrosis, the study underlines the synergistic interaction between steatosis and even low alcohol consumption as a contributory factor in extensive liver fibrosis.

Entities:  

Mesh:

Year:  2002        PMID: 12135040     DOI: 10.1111/j.1572-0241.2002.05793.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  24 in total

Review 1.  Metabolic syndrome and non-alcoholic fatty liver disease in liver surgery: The new scourges?

Authors:  François Cauchy; David Fuks; Alban Zarzavadjian Le Bian; Jacques Belghiti; Renato Costi
Journal:  World J Hepatol       Date:  2014-05-27

2.  Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation.

Authors:  Pierluigi Toniutto; Carlo Fabris; Claudio Avellini; Rosalba Minisini; Davide Bitetto; Elisabetta Rossi; Carlo Smirne; Mario Pirisi
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

3.  Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C.

Authors:  L Fartoux; A Poujol-Robert; J Guéchot; D Wendum; R Poupon; L Serfaty
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

4.  Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community.

Authors:  Sandra A Springer; Frederick L Altice; Maua Herme; Angela Di Paola
Journal:  Contemp Clin Trials       Date:  2013-12-31       Impact factor: 2.226

Review 5.  HIV, alcohol dependence, and the criminal justice system: a review and call for evidence-based treatment for released prisoners.

Authors:  Sandra A Springer; Marwan M Azar; Frederick L Altice
Journal:  Am J Drug Alcohol Abuse       Date:  2010-12-21       Impact factor: 3.829

6.  Changes in lipid metabolism in chronic hepatitis C.

Authors:  Katalin Jármay; Gizella Karácsony; András Nagy; Zsuzsa Schaff
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

7.  Public health implications for adequate transitional care for HIV-infected prisoners: five essential components.

Authors:  Sandra A Springer; Anne C Spaulding; Jaimie P Meyer; Frederick L Altice
Journal:  Clin Infect Dis       Date:  2011-09       Impact factor: 9.079

8.  Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C.

Authors:  T Asselah; N Boyer; M-C Guimont; D Cazals-Hatem; F Tubach; K Nahon; H Daïkha; D Vidaud; M Martinot; M Vidaud; C Degott; D Valla; P Marcellin
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

9.  The prevalence of bright liver echo pattern in patients with chronic hepatitis C: correlation with steatosis and fibrosis.

Authors:  Maurizio Loy; Giancarlo Serra; Luchino Chessa
Journal:  J Ultrasound       Date:  2014-07-05

10.  Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis.

Authors:  L Castéra; C Hézode; F Roudot-Thoraval; I Lonjon; E-S Zafrani; J-M Pawlotsky; D Dhumeaux
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.